SENP3 and carcinoma: Contrastively, in the pathological context, SENP3 may elicit a cellular response in case the fluctuations in its level influence the protein SUMOylation process, which results in cellular activity anomalies, as well as the disease contraction and development (e.g. neurological conditions, cardiovascular conditions, and various carcinomas).18